A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab-refractory iNHL (COMPLEMENT A + B study)
Loading...
Date
2021
Advisors/Reviewers
Further Contributors
Contributing Institutions
Publisher
Journal Title
Journal ISSN
Volume Title
Publisher
Quotable link
DOI:
http://dx.doi.org/10.22029/jlupub-9112Link to publications or other datasets
Description
Notes
Original publication in
British journal of haematology 193 (2021), 1123 - 1133